Denmark Antiemetics Drugs Market Size & Outlook, 2023-2030

The antiemetics drugs market in Denmark is expected to reach a projected revenue of US$ 29.0 million by 2030. A compound annual growth rate of 6.2% is expected of Denmark antiemetics drugs market from 2024 to 2030.
Revenue, 2023 (US$M)
$19.0
Forecast, 2030 (US$M)
$29.0
CAGR, 2024 - 2030
6.2%
Report Coverage
Denmark

Denmark antiemetics drugs market highlights

  • The Denmark antiemetics drugs market generated a revenue of USD 19.0 million in 2023 and is expected to reach USD 29.0 million by 2030.
  • The Denmark market is expected to grow at a CAGR of 6.2% from 2024 to 2030.
  • In terms of segment, serotonin-receptor antagonists was the largest revenue generating drug type in 2023.
  • Serotonin-Receptor Antagonists is the most lucrative drug type segment registering the fastest growth during the forecast period.


Antiemetics drugs market data book summary

Market revenue in 2023USD 19.0 million
Market revenue in 2030USD 29.0 million
Growth rate6.2% (CAGR from 2023 to 2030)
Largest segmentSerotonin-receptor antagonists
Fastest growing segmentSerotonin-Receptor Antagonists
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSerotonin-Receptor Antagonists, Anticholinergics, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, Other Drug Types (Antihistamines, Cannabinoids, Glucocorticoids)
Key market players worldwidePfizer Inc, Cipla Ltd DR, Merck KGaA, Eagle Pharmaceuticals Inc, Johnson & Johnson, GSK PLC ADR, Astellas Pharma Inc, Viatris Inc, Baxter International Inc, Glenmark Pharmaceuticals


Other key industry trends

  • In terms of revenue, Denmark accounted for 0.3% of the global antiemetics drugs market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, UK antiemetics drugs market is projected to lead the regional market in terms of revenue in 2030.
  • Italy is the fastest growing regional market in Europe and is projected to reach USD 314.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Antiemetics Drugs Market Scope

Antiemetics drugs market segmentation & scope
Serotonin-Receptor Antagonists
Anticholinergics
Dopamine Receptor Antagonists
Neurokinin Receptor Antagonists
Other Drug Types (Antihistamines, Cannabinoids, Glucocorticoids)
Chemotherapy
Gatroenteritis
Post Operative Surgery
Other Applications (Vertigo, Motion Sickness)
Hospital & Clinics
Retail Pharmacy
Other End-use

Antiemetics Drugs Market Companies

Name Profile # Employees HQ Website

Denmark antiemetics drugs market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antiemetics drugs market will help companies and investors design strategic landscapes.


Serotonin-receptor antagonists was the largest segment with a revenue share of 29.47% in 2023. Horizon Databook has segmented the Denmark antiemetics drugs market based on serotonin-receptor antagonists, anticholinergics, dopamine receptor antagonists, neurokinin receptor antagonists, other drug types (antihistamines, cannabinoids, glucocorticoids) covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Denmark antiemetics drugs market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Denmark antiemetics drugs market databook

  • Our clientele includes a mix of antiemetics drugs market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Denmark antiemetics drugs market , including forecasts for subscribers. This country databook contains high-level insights into Denmark antiemetics drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Denmark antiemetics drugs market size, by drug type, 2018-2030 (US$M)

Denmark Antiemetics Drugs Market Outlook Share, 2023 & 2030 (US$M)

Denmark antiemetics drugs market size, by drug type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more